New Psychoactive Substances, Edition 6

In 2017, 51 new compounds were reported to the EMCDDA for the first time, bringing the total number of substances monitored to more than 670. Following a high of 101 substances notified in 2014, the number has decreased. Whilst this is a positive trend, the concerning development in the market has been the significant increase in the availability of new synthetic opioids. A total of 38 have been reported with highly potent fentanils (n=28) dominating. 


Chiron work closely with clinical and forensic institutions to proactively meet demand for NPS reference materials. Edition 6 of our NPS catalogue showcases our impressive range of available standards in this field. We now also provide mixes of NPS as well as custom made solutions.